Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Other Working Capital Changes (2020 - 2025)

Bioventus (BVS) has disclosed Other Working Capital Changes for 6 consecutive years, with $673000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes fell 90.88% year-over-year to $673000.0, compared with a TTM value of $1.7 million through Dec 2025, down 33.5%, and an annual FY2025 reading of $1.7 million, down 33.5% over the prior year.
  • Other Working Capital Changes was $673000.0 for Q4 2025 at Bioventus, down from $2.3 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $12.6 million in Q3 2021 and bottomed at -$12.6 million in Q4 2021.
  • Average Other Working Capital Changes over 5 years is $344350.0, with a median of $284000.0 recorded in 2023.
  • The sharpest move saw Other Working Capital Changes plummeted 9448.48% in 2021, then soared 2310.78% in 2024.
  • Year by year, Other Working Capital Changes stood at $181000.0 in 2021, then rose by 22.65% to $222000.0 in 2022, then skyrocketed by 37.84% to $306000.0 in 2023, then skyrocketed by 2310.78% to $7.4 million in 2024, then crashed by 90.88% to $673000.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for BVS at $673000.0 in Q4 2025, $2.3 million in Q3 2025, and -$492000.0 in Q2 2025.